July 7, 2023 – Retia Medical, has been awarded a national group purchasing agreement for Hemodynamic Monitoring Products with Premier, Inc. Effective July 1st, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Argos Monitor.
Circulatory Shock in critically ill patients is a life-threatening condition characterized by a severe impairment in tissue perfusion, leading to inadequate oxygen and nutrient delivery to vital organs. Often misdiagnosed as hypotension, shock is a primary cause of complications such as acute kidney injury, cardiac injury, sepsis and more in the OR and in the ICU. When this happens, clinicians have 1-2 minutes to prevent damage to vital organs. Prompt recognition and appropriate resuscitation are crucial to improve patient outcomes. The management of shock in critically ill patients requires a timely intervention with hemodynamic-guided therapy to ensure sufficient oxygen delivery and minimize organ damage in these high-risk patients.
Retia Medical’s Argos System stands out in the market for its outstanding clinical performance having been proven in the toughest patient populations: cardiogenic shock, cardiac surgery, liver transplant, off pump cardiac surgery, neurosurgery, major abdominal surgery, heart failure and post-surgery in the ICU. Powered by its MBA algorithm, the Argos has the ability to detect early onsets of shock to ensure clinicians can guide the appropriate care management to those critically ill patients and avoid costly complications. Its minimally invasive nature and ability to integrate seamlessly with existing patient monitoring systems make it a valuable addition to healthcare facilities seeking to enhance their cardiac monitoring capabilities. With its simple one cable connection, the Argos system allows clinicians to monitor more patients without worrying about added costs associated with costly disposables.